-
SANOFI-AVENTIS U.S. LLC et al v. ACCORD HEALTHCARE, INC. DC CAFC
- 3:14-cv-08079
- D.N.J.
- Judge: Michael A. Shipp
+1
- Filed: 12/29/2014
- Closed: 09/26/2017
- Latest Docket Entry: 10/05/2019
- PACER
- Docket updated daily
3
Plaintiffs
1
Defendant
1
Accused
Product
1
Patent-in-Suit
1,003
Days in
Litigation
-
SANOFI-AVENTIS U.S. LLC et al v. ACCORD HEALTHCARE, INC. DC CAFC
- 3:14-cv-08079
- D.N.J.
- Judge: Michael A. Shipp
+1
- Filed: 12/29/2014
- Closed: 09/26/2017
- Latest Docket Entry: 10/05/2019
- PACER
- Docket updated daily
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
4.alph a.-Acetoxy-2.alpha.-benzoyloxy-5.beta.,20-epoxy-1.beta.-hydroxy-7.beta.,10.beta.-dimethoxy-9-oxo-11-taxen-13.alpha.-yl(2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate.
|
Valid (101 and 103)
Entry 27 |
| 2 |
A pharmaceutical composition comprising at least the product according to claim 1 in combination with one or more pharmaceutically acceptable diluents or adjuvants and optionally one or more compatible and pharmacologically active compounds.
|
Valid (101 and 103)
Entry 27 |
-
Infringement
Accord Healthcare Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Cabazitaxel Injection 60mg/1.5 mL | US 5,847,170 A |
1, 2
|
Infringement
Entry 27
|
